Tango Therapeutics CFO Daniella Beckman Separates; Severance Includes 12-Month Pay, Equity Acceleration

Tango Therapeutics, Inc.

CFO Daniella Beckman ceased serving as principal financial officer effective April 15, 2026.
Separation agreement provides 12 months severance at current base salary paid over 12 months.
Company accelerates vesting of equity awards that would have vested in 24 months following May 1, 2026.
Vested stock options exercise period extended through August 31, 2026.
Beckman executed a general release in favor of the Company.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Daniella Beckman

Chief Financial Officer

TNGX · Tango Therapeutics, Inc.

Effective: 2026-04-15
Filed: May 8, 2026, 7:59 PM ET

on April 10, 2026, the board of directors (the “Board”) of Tango Therapeutics, Inc. (the “Company”) determined that Daniella Beckman will no longer serve as the Company’s Chief Financial Officer, principal accounting officer and principal financial officer, effective as of April 15, 2026.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Daniella Beckman departed as Chief Financial Officer at Tango Therapeutics, Inc..

Action: ceased serving
Role: Chief Financial Officer

Exact text from the filing

on April 10, 2026, the board of directors (the “Board”) of Tango Therapeutics, Inc. (the “Company”) determined that Daniella Beckman will no longer serve as the Company’s Chief Financial Officer, principal accounting officer and principal financial officer, effective as of April 15, 2026.

View on SEC.gov

Tango Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-26-213491

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.